Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-002594
Filing Date
2025-04-03
Accepted
2025-04-03 17:00:36
Documents
64
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1359941
2 ex19-1.htm EX-19.1 113348
3 ex31-1.htm EX-31.1 18205
4 ex31-2.htm EX-31.2 17881
5 ex32-1.htm EX-32.1 6906
6 ex32-2.htm EX-32.2 6941
  Complete submission text file 0001641172-25-002594.txt   5465926

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE acut-20241231.xsd EX-101.SCH 32734
8 XBRL CALCULATION FILE acut-20241231_cal.xml EX-101.CAL 43165
9 XBRL DEFINITION FILE acut-20241231_def.xml EX-101.DEF 129735
10 XBRL LABEL FILE acut-20241231_lab.xml EX-101.LAB 361568
11 XBRL PRESENTATION FILE acut-20241231_pre.xml EX-101.PRE 272938
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 615311
Mailing Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001 442070661000
Accustem Sciences Inc. (Filer) CIK: 0001850767 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56257 | Film No.: 25810524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)